v3.26.1
Fair Value Measurements - Schedule of fair value on a recurring basis (Details) - USD ($)
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Recurring fair value measurements    
Total (gains) losses for period included in earnings $ (215,541) $ 1,215,624
2024 October Institutional/Accredited Investor Warrants    
Recurring fair value measurements    
Balance at period start 1,403  
Initial fair value 0  
Interest Expense 0  
Conversion of Convertible Notes 0  
Total (gains) losses for period included in earnings (1,403) (265,178)
Balance at period end 0  
2025 May Institutional/Accredited Investor Warrants    
Recurring fair value measurements    
Balance at period start 11,272  
Initial fair value 0  
Interest Expense 0  
Conversion of Convertible Notes 0  
Total (gains) losses for period included in earnings (11,272) 0
Balance at period end 0  
2025 September Institutional/Accredited Investor Warrants    
Recurring fair value measurements    
Balance at period start 2,862  
Initial fair value 0  
Interest Expense 0  
Conversion of Convertible Notes 0  
Total (gains) losses for period included in earnings (2,862) 0
Balance at period end 0  
Senior Convertible Notes - September 2025    
Recurring fair value measurements    
Balance at period start 112,302  
Initial fair value 0  
Interest Expense 4,768  
Conversion of Convertible Notes 0  
Total (gains) losses for period included in earnings 0 0
Balance at period end 117,070  
2025 November Institutional/Accredited Investor Warrants    
Recurring fair value measurements    
Balance at period start 12,311  
Initial fair value 0  
Interest Expense 0  
Conversion of Convertible Notes 0  
Total (gains) losses for period included in earnings (12,311) 0
Balance at period end 0  
Senior Convertible Notes - November 2025    
Recurring fair value measurements    
Balance at period start 281,185  
Initial fair value 0  
Interest Expense 4,898  
Conversion of Convertible Notes (40,218)  
Total (gains) losses for period included in earnings 0 0
Balance at period end 245,865  
2025 December 17 and 26 Institutional/Accredited Investor Warrants    
Recurring fair value measurements    
Balance at period start 9,848  
Initial fair value 0  
Interest Expense 0  
Conversion of Convertible Notes 0  
Total (gains) losses for period included in earnings (9,848) 0
Balance at period end 0  
Senior Convertible Notes - December 17 and 26 2025    
Recurring fair value measurements    
Balance at period start 222,691  
Initial fair value 0  
Interest Expense 4,484  
Conversion of Convertible Notes (222,222)  
Total (gains) losses for period included in earnings 0 0
Balance at period end 4,953  
2025 December 30 Institutional/Accredited Investor Warrants and AIR    
Recurring fair value measurements    
Balance at period start 436,327  
Initial fair value 0  
Interest Expense 0  
Conversion of Convertible Notes 0  
Total (gains) losses for period included in earnings (177,845) $ 0
Balance at period end 258,482  
2026 January Institutional/Accredited Investor Warrants    
Recurring fair value measurements    
Balance at period start 0  
Initial fair value 6,559  
Interest Expense 0  
Conversion of Convertible Notes 0  
Total (gains) losses for period included in earnings 0  
Balance at period end 6,559  
2026 February Institutional/Accredited Investor Warrants    
Recurring fair value measurements    
Balance at period start 0  
Initial fair value 7,411  
Interest Expense 0  
Conversion of Convertible Notes 0  
Total (gains) losses for period included in earnings 0  
Balance at period end 7,411  
2026 March 6 Institutional/Accredited Investor Warrants    
Recurring fair value measurements    
Balance at period start 0  
Initial fair value 9,306  
Interest Expense 0  
Conversion of Convertible Notes 0  
Total (gains) losses for period included in earnings 0  
Balance at period end 9,306  
2026 March 27 Institutional/Accredited Investor Warrants    
Recurring fair value measurements    
Balance at period start 0  
Initial fair value 54,754  
Interest Expense 0  
Conversion of Convertible Notes 0  
Total (gains) losses for period included in earnings 0  
Balance at period end $ 54,754